Physician profile
Samar Nahas
NPI 1831478395
$132,003.13
in general payments reported to CMS, 2019-2025
8 companies · $19K in 2025
The $19K reported for 2025 was more than what 97% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $22K · 2021: $21K · 2022: $26K · 2023: $12K · 2024: $12K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Travel and Lodging: $4,770 · Education: $3,000 · Food and Beverage: $1,764 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,500.00 |
| Travel and Lodging | $4,770.32 |
| Education | $3,000.00 |
| Food and Beverage | $1,764.09 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $76,407.74 | 2021-2025 | Truclear, Ligasure |
| Covidien Lp | $38,241.94 | 2019-2020 | |
| Coopersurgical, INC. | $8,886.84 | 2021-2022 | |
| Intuitive Surgical, INC. | $4,664.72 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals Lp | $3,528.73 | 2019 | |
| Avanos Medical | $142.51 | 2019 | |
| Medical Device Business Services, INC. | $102.20 | 2019 | |
| Karl Storz Endoscopy-America | $28.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samar Nahas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.